Laurence E. Reid

2013

In 2013, Laurence E. Reid earned a total compensation of $1.2M as Senior Vice President and Chief Business Officer at Alnylam Pharmaceuticals, a 25% increase compared to previous year.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$161,250
Option Awards$645,154
Salary$375,000
Other$7,182
Total$1,213,586

Reid received $645.2K in option awards, accounting for 53% of the total pay in 2013.

Reid also received $25K in bonus, $161.3K in non-equity incentive plan, $375K in salary and $7.2K in other compensation.

Rankings

In 2013, Laurence E. Reid's compensation ranked 5,806th out of 12,286 executives tracked by ExecPay. In other words, Reid earned more than 52.7% of executives.

ClassificationRankingPercentile
All
5,806
out of 12,286
53rd
Division
Manufacturing
2,016
out of 4,612
56th
Major group
Chemicals And Allied Products
590
out of 1,462
60th
Industry group
Drugs
423
out of 1,156
63rd
Industry
Pharmaceutical Preparations
341
out of 890
62nd
Source: SEC filing on April 29, 2014.

Reid's colleagues

We found four more compensation records of executives who worked with Laurence E. Reid at Alnylam Pharmaceuticals in 2013.

2013

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2013

Barry Greene

Alnylam Pharmaceuticals

Chief Operating Officer

2013

Akshay Vaishnaw

Alnylam Pharmaceuticals

Chief Medical Officer

2013

Michael Mason

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer principal financial officer

In-depth

You may also like